Global Hip Osteoarthritis Pain Drug Market Insights and Forecast to 2026

Publisher Name :
Date: 07-Aug-2020
No. of pages: 152
Inquire Before Buying

Hip Osteoarthritis Pain Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hip Osteoarthritis Pain Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Hip Osteoarthritis Pain Drug market is segmented into

- Oral

- Injection

- External

Segment by Application, the Hip Osteoarthritis Pain Drug market is segmented into

- Medical Care

- Personal Care

Regional and Country-level Analysis

The Hip Osteoarthritis Pain Drug market is analysed and market size information is provided by regions (countries).

The key regions covered in the Hip Osteoarthritis Pain Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Hip Osteoarthritis Pain Drug Market Share Analysis

Hip Osteoarthritis Pain Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hip Osteoarthritis Pain Drug business, the date to enter into the Hip Osteoarthritis Pain Drug market, Hip Osteoarthritis Pain Drug product introduction, recent developments, etc.

The major vendors covered:

- Pfizer

- Johnson and Johnson

- GlaxoSmithKline

- Bayer

- Eli Lilly

- Novartis

- Sanofi

- Horizon Pharma

- Abbott

- Mylan

- Daiichi Sankyo

- TEVA

- Almatica Pharma

- Astellas Pharma

- Tide Pharmaceutical

- Iroko Pharmaceuticals

- Hengrui Pharmaceutical

- Abiogen Pharma

Global Hip Osteoarthritis Pain Drug Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Hip Osteoarthritis Pain Drug Product Introduction
1.2 Market Segments
1.3 Key Hip Osteoarthritis Pain Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hip Osteoarthritis Pain Drug Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.4.4 External
1.5 Market by Application
1.5.1 Global Hip Osteoarthritis Pain Drug Market Size Growth Rate by Application
1.5.2 Medical Care
1.5.3 Personal Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hip Osteoarthritis Pain Drug Market Size, Estimates and Forecasts
2.1.1 Global Hip Osteoarthritis Pain Drug Revenue 2015-2026
2.1.2 Global Hip Osteoarthritis Pain Drug Sales 2015-2026
2.2 Global Hip Osteoarthritis Pain Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hip Osteoarthritis Pain Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hip Osteoarthritis Pain Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hip Osteoarthritis Pain Drug Competitor Landscape by Players
3.1 Hip Osteoarthritis Pain Drug Sales by Manufacturers
3.1.1 Hip Osteoarthritis Pain Drug Sales by Manufacturers (2015-2020)
3.1.2 Hip Osteoarthritis Pain Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Hip Osteoarthritis Pain Drug Revenue by Manufacturers
3.2.1 Hip Osteoarthritis Pain Drug Revenue by Manufacturers (2015-2020)
3.2.2 Hip Osteoarthritis Pain Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hip Osteoarthritis Pain Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hip Osteoarthritis Pain Drug Revenue in 2019
3.2.5 Global Hip Osteoarthritis Pain Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hip Osteoarthritis Pain Drug Price by Manufacturers
3.4 Hip Osteoarthritis Pain Drug Manufacturing Base Distribution, Product Types
3.4.1 Hip Osteoarthritis Pain Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hip Osteoarthritis Pain Drug Product Type
3.4.3 Date of International Manufacturers Enter into Hip Osteoarthritis Pain Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hip Osteoarthritis Pain Drug Market Size by Type (2015-2020)
4.1.1 Global Hip Osteoarthritis Pain Drug Sales by Type (2015-2020)
4.1.2 Global Hip Osteoarthritis Pain Drug Revenue by Type (2015-2020)
4.1.3 Hip Osteoarthritis Pain Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hip Osteoarthritis Pain Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Hip Osteoarthritis Pain Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Hip Osteoarthritis Pain Drug Revenue Forecast by Type (2021-2026)
4.2.3 Hip Osteoarthritis Pain Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hip Osteoarthritis Pain Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hip Osteoarthritis Pain Drug Market Size by Application (2015-2020)
5.1.1 Global Hip Osteoarthritis Pain Drug Sales by Application (2015-2020)
5.1.2 Global Hip Osteoarthritis Pain Drug Revenue by Application (2015-2020)
5.1.3 Hip Osteoarthritis Pain Drug Price by Application (2015-2020)
5.2 Hip Osteoarthritis Pain Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Hip Osteoarthritis Pain Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Hip Osteoarthritis Pain Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Hip Osteoarthritis Pain Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hip Osteoarthritis Pain Drug by Country
6.1.1 North America Hip Osteoarthritis Pain Drug Sales by Country
6.1.2 North America Hip Osteoarthritis Pain Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hip Osteoarthritis Pain Drug Market Facts & Figures by Type
6.3 North America Hip Osteoarthritis Pain Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Hip Osteoarthritis Pain Drug by Country
7.1.1 Europe Hip Osteoarthritis Pain Drug Sales by Country
7.1.2 Europe Hip Osteoarthritis Pain Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hip Osteoarthritis Pain Drug Market Facts & Figures by Type
7.3 Europe Hip Osteoarthritis Pain Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hip Osteoarthritis Pain Drug by Region
8.1.1 Asia Pacific Hip Osteoarthritis Pain Drug Sales by Region
8.1.2 Asia Pacific Hip Osteoarthritis Pain Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hip Osteoarthritis Pain Drug Market Facts & Figures by Type
8.3 Asia Pacific Hip Osteoarthritis Pain Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hip Osteoarthritis Pain Drug by Country
9.1.1 Latin America Hip Osteoarthritis Pain Drug Sales by Country
9.1.2 Latin America Hip Osteoarthritis Pain Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hip Osteoarthritis Pain Drug Market Facts & Figures by Type
9.3 Central & South America Hip Osteoarthritis Pain Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hip Osteoarthritis Pain Drug by Country
10.1.1 Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country
10.1.2 Middle East and Africa Hip Osteoarthritis Pain Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hip Osteoarthritis Pain Drug Market Facts & Figures by Type
10.3 Middle East and Africa Hip Osteoarthritis Pain Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Hip Osteoarthritis Pain Drug Products Offered
11.1.5 Pfizer Related Developments
11.2 Johnson and Johnson
11.2.1 Johnson and Johnson Corporation Information
11.2.2 Johnson and Johnson Description and Business Overview
11.2.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Johnson and Johnson Hip Osteoarthritis Pain Drug Products Offered
11.2.5 Johnson and Johnson Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Hip Osteoarthritis Pain Drug Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description and Business Overview
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Hip Osteoarthritis Pain Drug Products Offered
11.4.5 Bayer Related Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Corporation Information
11.5.2 Eli Lilly Description and Business Overview
11.5.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eli Lilly Hip Osteoarthritis Pain Drug Products Offered
11.5.5 Eli Lilly Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Hip Osteoarthritis Pain Drug Products Offered
11.6.5 Novartis Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Hip Osteoarthritis Pain Drug Products Offered
11.7.5 Sanofi Related Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Corporation Information
11.8.2 Horizon Pharma Description and Business Overview
11.8.3 Horizon Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Horizon Pharma Hip Osteoarthritis Pain Drug Products Offered
11.8.5 Horizon Pharma Related Developments
11.9 Abbott
11.9.1 Abbott Corporation Information
11.9.2 Abbott Description and Business Overview
11.9.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Abbott Hip Osteoarthritis Pain Drug Products Offered
11.9.5 Abbott Related Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Description and Business Overview
11.10.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Mylan Hip Osteoarthritis Pain Drug Products Offered
11.10.5 Mylan Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Hip Osteoarthritis Pain Drug Products Offered
11.1.5 Pfizer Related Developments
11.12 TEVA
11.12.1 TEVA Corporation Information
11.12.2 TEVA Description and Business Overview
11.12.3 TEVA Sales, Revenue and Gross Margin (2015-2020)
11.12.4 TEVA Products Offered
11.12.5 TEVA Related Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Corporation Information
11.13.2 Almatica Pharma Description and Business Overview
11.13.3 Almatica Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Almatica Pharma Products Offered
11.13.5 Almatica Pharma Related Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Corporation Information
11.14.2 Astellas Pharma Description and Business Overview
11.14.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Astellas Pharma Products Offered
11.14.5 Astellas Pharma Related Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Corporation Information
11.15.2 Tide Pharmaceutical Description and Business Overview
11.15.3 Tide Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Tide Pharmaceutical Products Offered
11.15.5 Tide Pharmaceutical Related Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Corporation Information
11.16.2 Iroko Pharmaceuticals Description and Business Overview
11.16.3 Iroko Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Iroko Pharmaceuticals Products Offered
11.16.5 Iroko Pharmaceuticals Related Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Corporation Information
11.17.2 Hengrui Pharmaceutical Description and Business Overview
11.17.3 Hengrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Hengrui Pharmaceutical Products Offered
11.17.5 Hengrui Pharmaceutical Related Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Corporation Information
11.18.2 Abiogen Pharma Description and Business Overview
11.18.3 Abiogen Pharma Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Abiogen Pharma Products Offered
11.18.5 Abiogen Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hip Osteoarthritis Pain Drug Market Estimates and Projections by Region
12.1.1 Global Hip Osteoarthritis Pain Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Hip Osteoarthritis Pain Drug Revenue Forecast by Regions 2021-2026
12.2 North America Hip Osteoarthritis Pain Drug Market Size Forecast (2021-2026)
12.2.1 North America: Hip Osteoarthritis Pain Drug Sales Forecast (2021-2026)
12.2.2 North America: Hip Osteoarthritis Pain Drug Revenue Forecast (2021-2026)
12.2.3 North America: Hip Osteoarthritis Pain Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Hip Osteoarthritis Pain Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Hip Osteoarthritis Pain Drug Sales Forecast (2021-2026)
12.3.2 Europe: Hip Osteoarthritis Pain Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Hip Osteoarthritis Pain Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hip Osteoarthritis Pain Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hip Osteoarthritis Pain Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hip Osteoarthritis Pain Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hip Osteoarthritis Pain Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Hip Osteoarthritis Pain Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Hip Osteoarthritis Pain Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Hip Osteoarthritis Pain Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Hip Osteoarthritis Pain Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hip Osteoarthritis Pain Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hip Osteoarthritis Pain Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hip Osteoarthritis Pain Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hip Osteoarthritis Pain Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hip Osteoarthritis Pain Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hip Osteoarthritis Pain Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Hip Osteoarthritis Pain Drug Market Segments
Table 2. Ranking of Global Top Hip Osteoarthritis Pain Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hip Osteoarthritis Pain Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. Major Manufacturers of External
Table 7. Global Hip Osteoarthritis Pain Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Hip Osteoarthritis Pain Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Hip Osteoarthritis Pain Drug Sales by Regions 2015-2020 (K Units)
Table 10. Global Hip Osteoarthritis Pain Drug Sales Market Share by Regions (2015-2020)
Table 11. Global Hip Osteoarthritis Pain Drug Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Hip Osteoarthritis Pain Drug Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Hip Osteoarthritis Pain Drug Sales Share by Manufacturers (2015-2020)
Table 14. Global Hip Osteoarthritis Pain Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Hip Osteoarthritis Pain Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hip Osteoarthritis Pain Drug as of 2019)
Table 16. Hip Osteoarthritis Pain Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Hip Osteoarthritis Pain Drug Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Hip Osteoarthritis Pain Drug Price (2015-2020) (USD/Unit)
Table 19. Hip Osteoarthritis Pain Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Hip Osteoarthritis Pain Drug Product Type
Table 21. Date of International Manufacturers Enter into Hip Osteoarthritis Pain Drug Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Hip Osteoarthritis Pain Drug Sales by Type (2015-2020) (K Units)
Table 24. Global Hip Osteoarthritis Pain Drug Sales Share by Type (2015-2020)
Table 25. Global Hip Osteoarthritis Pain Drug Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Hip Osteoarthritis Pain Drug Revenue Share by Type (2015-2020)
Table 27. Hip Osteoarthritis Pain Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Hip Osteoarthritis Pain Drug Sales by Application (2015-2020) (K Units)
Table 29. Global Hip Osteoarthritis Pain Drug Sales Share by Application (2015-2020)
Table 30. North America Hip Osteoarthritis Pain Drug Sales by Country (2015-2020) (K Units)
Table 31. North America Hip Osteoarthritis Pain Drug Sales Market Share by Country (2015-2020)
Table 32. North America Hip Osteoarthritis Pain Drug Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2015-2020)
Table 34. North America Hip Osteoarthritis Pain Drug Sales by Type (2015-2020) (K Units)
Table 35. North America Hip Osteoarthritis Pain Drug Sales Market Share by Type (2015-2020)
Table 36. North America Hip Osteoarthritis Pain Drug Sales by Application (2015-2020) (K Units)
Table 37. North America Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)
Table 38. Europe Hip Osteoarthritis Pain Drug Sales by Country (2015-2020) (K Units)
Table 39. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Country (2015-2020)
Table 40. Europe Hip Osteoarthritis Pain Drug Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2015-2020)
Table 42. Europe Hip Osteoarthritis Pain Drug Sales by Type (2015-2020) (K Units)
Table 43. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Type (2015-2020)
Table 44. Europe Hip Osteoarthritis Pain Drug Sales by Application (2015-2020) (K Units)
Table 45. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Hip Osteoarthritis Pain Drug Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Hip Osteoarthritis Pain Drug Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Hip Osteoarthritis Pain Drug Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Hip Osteoarthritis Pain Drug Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Hip Osteoarthritis Pain Drug Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)
Table 54. Latin America Hip Osteoarthritis Pain Drug Sales by Country (2015-2020) (K Units)
Table 55. Latin America Hip Osteoarthritis Pain Drug Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Hip Osteoarthritis Pain Drug Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2015-2020)
Table 58. Latin America Hip Osteoarthritis Pain Drug Sales by Type (2015-2020) (K Units)
Table 59. Latin America Hip Osteoarthritis Pain Drug Sales Market Share by Type (2015-2020)
Table 60. Latin America Hip Osteoarthritis Pain Drug Sales by Application (2015-2020) (K Units)
Table 61. Latin America Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Major Businesses
Table 72. Pfizer Hip Osteoarthritis Pain Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Pfizer Product
Table 74. Pfizer Recent Development
Table 75. Johnson and Johnson Corporation Information
Table 76. Johnson and Johnson Description and Major Businesses
Table 77. Johnson and Johnson Hip Osteoarthritis Pain Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Johnson and Johnson Product
Table 79. Johnson and Johnson Recent Development
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Major Businesses
Table 82. GlaxoSmithKline Hip Osteoarthritis Pain Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Product
Table 84. GlaxoSmithKline Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Major Businesses
Table 87. Bayer Hip Osteoarthritis Pain Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bayer Product
Table 89. Bayer Recent Development
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Major Businesses
Table 92. Eli Lilly Hip Osteoarthritis Pain Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Eli Lilly Product
Table 94. Eli Lilly Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Major Businesses
Table 97. Novartis Hip Osteoarthritis Pain Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Novartis Product
Table 99. Novartis Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Major Businesses
Table 102. Sanofi Hip Osteoarthritis Pain Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sanofi Product
Table 104. Sanofi Recent Development
Table 105. Horizon Pharma Corporation Information
Table 106. Horizon Pharma Description and Major Businesses
Table 107. Horizon Pharma Hip Osteoarthritis Pain Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Horizon Pharma Product
Table 109. Horizon Pharma Recent Development
Table 110. Abbott Corporation Information
Table 111. Abbott Description and Major Businesses
Table 112. Abbott Hip Osteoarthritis Pain Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Abbott Product
Table 114. Abbott Recent Development
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Major Businesses
Table 117. Mylan Hip Osteoarthritis Pain Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Mylan Product
Table 119. Mylan Recent Development
Table 120. Daiichi Sankyo Corporation Information
Table 121. Daiichi Sankyo Description and Major Businesses
Table 122. Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Daiichi Sankyo Product
Table 124. Daiichi Sankyo Recent Development
Table 125. TEVA Corporation Information
Table 126. TEVA Description and Major Businesses
Table 127. TEVA Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. TEVA Product
Table 129. TEVA Recent Development
Table 130. Almatica Pharma Corporation Information
Table 131. Almatica Pharma Description and Major Businesses
Table 132. Almatica Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Almatica Pharma Product
Table 134. Almatica Pharma Recent Development
Table 135. Astellas Pharma Corporation Information
Table 136. Astellas Pharma Description and Major Businesses
Table 137. Astellas Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Astellas Pharma Product
Table 139. Astellas Pharma Recent Development
Table 140. Tide Pharmaceutical Corporation Information
Table 141. Tide Pharmaceutical Description and Major Businesses
Table 142. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Tide Pharmaceutical Product
Table 144. Tide Pharmaceutical Recent Development
Table 145. Iroko Pharmaceuticals Corporation Information
Table 146. Iroko Pharmaceuticals Description and Major Businesses
Table 147. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Iroko Pharmaceuticals Product
Table 149. Iroko Pharmaceuticals Recent Development
Table 150. Hengrui Pharmaceutical Corporation Information
Table 151. Hengrui Pharmaceutical Description and Major Businesses
Table 152. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Hengrui Pharmaceutical Product
Table 154. Hengrui Pharmaceutical Recent Development
Table 155. Abiogen Pharma Corporation Information
Table 156. Abiogen Pharma Description and Major Businesses
Table 157. Abiogen Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Abiogen Pharma Product
Table 159. Abiogen Pharma Recent Development
Table 160. Global Hip Osteoarthritis Pain Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 161. Global Hip Osteoarthritis Pain Drug Sales Market Share Forecast by Regions (2021-2026)
Table 162. Global Hip Osteoarthritis Pain Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 163. Global Hip Osteoarthritis Pain Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 164. North America: Hip Osteoarthritis Pain Drug Sales Forecast by Country (2021-2026) (K Units)
Table 165. North America: Hip Osteoarthritis Pain Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Europe: Hip Osteoarthritis Pain Drug Sales Forecast by Country (2021-2026) (K Units)
Table 167. Europe: Hip Osteoarthritis Pain Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Asia Pacific: Hip Osteoarthritis Pain Drug Sales Forecast by Region (2021-2026) (K Units)
Table 169. Asia Pacific: Hip Osteoarthritis Pain Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 170. Latin America: Hip Osteoarthritis Pain Drug Sales Forecast by Country (2021-2026) (K Units)
Table 171. Latin America: Hip Osteoarthritis Pain Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Middle East and Africa: Hip Osteoarthritis Pain Drug Sales Forecast by Country (2021-2026) (K Units)
Table 173. Middle East and Africa: Hip Osteoarthritis Pain Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 174. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 175. Key Challenges
Table 176. Market Risks
Table 177. Main Points Interviewed from Key Hip Osteoarthritis Pain Drug Players
Table 178. Hip Osteoarthritis Pain Drug Customers List
Table 179. Hip Osteoarthritis Pain Drug Distributors List
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Hip Osteoarthritis Pain Drug Product Picture
Figure 2. Global Hip Osteoarthritis Pain Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. External Product Picture
Figure 6. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application in 2020 & 2026
Figure 7. Medical Care
Figure 8. Personal Care
Figure 9. Hip Osteoarthritis Pain Drug Report Years Considered
Figure 10. Global Hip Osteoarthritis Pain Drug Market Size 2015-2026 (US$ Million)
Figure 11. Global Hip Osteoarthritis Pain Drug Sales 2015-2026 (K Units)
Figure 12. Global Hip Osteoarthritis Pain Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Hip Osteoarthritis Pain Drug Sales Market Share by Region (2015-2020)
Figure 14. Global Hip Osteoarthritis Pain Drug Sales Market Share by Region in 2019
Figure 15. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Region (2015-2020)
Figure 16. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Region in 2019
Figure 17. Global Hip Osteoarthritis Pain Drug Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Hip Osteoarthritis Pain Drug Revenue in 2019
Figure 19. Hip Osteoarthritis Pain Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Hip Osteoarthritis Pain Drug Sales Market Share by Type (2015-2020)
Figure 21. Global Hip Osteoarthritis Pain Drug Sales Market Share by Type in 2019
Figure 22. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Type (2015-2020)
Figure 23. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Type in 2019
Figure 24. Global Hip Osteoarthritis Pain Drug Market Share by Price Range (2015-2020)
Figure 25. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)
Figure 26. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application in 2019
Figure 27. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Application (2015-2020)
Figure 28. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Application in 2019
Figure 29. North America Hip Osteoarthritis Pain Drug Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Hip Osteoarthritis Pain Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Hip Osteoarthritis Pain Drug Sales Market Share by Country in 2019
Figure 32. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Country in 2019
Figure 33. U.S. Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Hip Osteoarthritis Pain Drug Market Share by Type in 2019
Figure 38. North America Hip Osteoarthritis Pain Drug Market Share by Application in 2019
Figure 39. Europe Hip Osteoarthritis Pain Drug Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Hip Osteoarthritis Pain Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Country in 2019
Figure 42. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Country in 2019
Figure 43. Germany Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Hip Osteoarthritis Pain Drug Sales Growth Rate
  • Pharmacy Benefit Management Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026
    Published: 21-Sep-2020        Price: US 4580 Onwards        Pages: 150
    The study predicts the short term and long term trends that can shape up the future of the Pharmacy Benefit Management market including the COVID-19 pandemic implications for Pharmacy Benefit Managements industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on marke......
  • Pharmaceutical Contract Manufacturing Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026
    Published: 21-Sep-2020        Price: US 4580 Onwards        Pages: 150
    The study predicts the short term and long term trends that can shape up the future of the Pharmaceutical Contract Manufacturing market including the COVID-19 pandemic implications for Pharmaceutical Contract Manufacturings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysi......
  • Empty Capsules Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026
    Published: 21-Sep-2020        Price: US 4580 Onwards        Pages: 150
    The study predicts the short term and long term trends that can shape up the future of the Empty Capsules market including the COVID-19 pandemic implications for Empty Capsuless industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies. ......
  • Carcinoembryonic Antigen Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026
    Published: 21-Sep-2020        Price: US 4580 Onwards        Pages: 150
    The study predicts the short term and long term trends that can shape up the future of the Carcinoembryonic Antigen market including the COVID-19 pandemic implications for Carcinoembryonic Antigens industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and......
  • Global Halal Pharmaceuticals Market Growth 2020-2025
    Published: 21-Sep-2020        Price: US 3660 Onwards        Pages: 134
    According to this study, over the next five years the Halal Pharmaceuticals market will register a 13.2%% CAGR in terms of revenue, the global market size will reach $ 490.8 million by 2025, from $ 299.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Halal Pharmaceuticals business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Halal Pharmaceuticals......
  • Global Erythropoietin Market Growth 2020-2025
    Published: 21-Sep-2020        Price: US 3660 Onwards        Pages: 133
    According to this study, over the next five years the Erythropoietin market will register a 6.0%% CAGR in terms of revenue, the global market size will reach $ 10070 million by 2025, from $ 7969.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Erythropoietin business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Erythropoietin market by product ty......
  • Global Pharma & Cosmetics Market Growth 2020-2025
    Published: 21-Sep-2020        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the Pharma & Cosmetics market will register a 3.4%% CAGR in terms of revenue, the global market size will reach $ 1808130 million by 2025, from $ 1580360 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pharma & Cosmetics business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Pharma & Cosmetics marke......
  • Global and China Nuclear Medicine & Radiopharmaceuticals Market Insights, Forecast to 2026
    Published: 18-Sep-2020        Price: US 3900 Onwards        Pages: 142
    Nuclear Medicine & Radiopharmaceuticals market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine & Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Typ......
  • Global and China Facial Injections Market Insights, Forecast to 2026
    Published: 18-Sep-2020        Price: US 3900 Onwards        Pages: 134
    Facial Injections market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Facial Injections market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Facial Injections market is segmented......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs